Skip to main content

Advertisement

SpringerLink
Log in

Sweet old memories: a review of the experimental models of the association between diabetes, senility and dementia

  • Review Article
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract7

As the burden of Alzheimer’s dementia rises, so does our understanding of the cellular and molecular basis of this neurodegenerative disease. Some of the recent advances in the aetiopathogenesis of neurodegeneration include the finding that insulin receptor signalling is key to neurogenesis and synaptogenesis in the brain, especially in areas related to memory formation and storage, including the hippocampus. This suggests an association between impaired insulin receptor signalling and neurodegenerative events. To decipher this association, several animal models are being employed. Such models include transgenic and non-transgenic animals that range from invertebrates (Drosophila melanogaster and Caenorhabditis elegans), to vertebrates (mouse, rats and primates). The current review is an account of such models and how they have contributed to our understanding of the relationship between type 2 diabetes mellitus, ageing and dementia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Adams JP, Sweatt JD (2002) Molecular psychology: roles for the ERK MAP kinase cascade in memory. Annu Rev Pharmacol Toxicol 42:135–163

    Article  CAS  PubMed  Google Scholar 

  • Ahmad W (2013) Overlapped metabolic and therapeutic links between Alzheimer and diabetes. Mol Neurobiol 47:399–424

    Article  CAS  PubMed  Google Scholar 

  • Akinola OB, Omotoso GO, Dosumu OO, Akinola OS, Olotufore F (2011) Diabetes-induced prefrontal Nissl substance deficit and the effects of neem-bitter leaf extract treatment. Int J Morphol 29:850–856

    Article  Google Scholar 

  • Akinola OB, Gabriel M, Suleiman A, Olorunsogbon (2012) Treatment of alloxan-induced diabetic rats with metformin or glitazones is associated with amelioration of hyperglycaemia and neuroprotection. The Open Diabetes J 5:8–12

    Article  CAS  Google Scholar 

  • Akinola O, Biliaminu S, Adediran R, Adeniye K, Abdulquadir F (2015) Characterization of prefrontal cortex microstructure and antioxidant status in a rat model of neurodegeneration induced by aluminium chloride and multiple low-dose streptozotocin. Metab Brain Dis 30:1531–1536

    Article  CAS  PubMed  Google Scholar 

  • Alzheimer’s Disease International 2015. World Alzheimer’s report 2015

  • Barron AM, Rosario ER, Elteriefi R, Pike CJ (2013) Sex-specific effects of high fat diet on indices of metabolic syndrome in 3xTg-AD mice: implications for Alzheimer’s disease. PLoS One 8:e78554

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bondy SC (2016) Low levels of aluminum can lead to behavioral and morphological changes associated with Alzheimer’s disease and age-related neurodegeneration. Neurotoxicology 52:222–229

    Article  CAS  PubMed  Google Scholar 

  • Cao D, Lu H, Lewis TL, Li L (2007) Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease. J Biol Chem 282:36275–36282

    Article  CAS  PubMed  Google Scholar 

  • Carvalho C, Cardoso S, Correia SC, Santos RX, Santos MS, Baldeiras I, Oliveira CR, Moreira PI (2012) Metabolic alterations induced by sucrose intake and Alzheimer’s disease promote similar brain mitochiondrial abnormalities. Diabetes 61(5):1234–1242

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen, Y., Tian, Z., Liang, Z., Sun, S., Dai, C.-I. & Lee, M. H. 2012. Brain gene expression of a sporadic (icv-STZ mouse) and a familial mouse model (3xTg-AD mouse) of Alzheimer’s disease. PLoS One, 7:e51432

  • Cohen E, Bieschke J, Perciavalle RM, Kelly JW, Dillin A (2006) Opposing activities protect against age-onset proteotoxicity, vol 313. Science, pp. 1604–1610

  • Correia SC, Santos RX, Carvalho C, Cardoso S, Candeias E (2012) Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer’s disease and diabetes interrelation. Brain Res 1441:64–78

    Article  CAS  PubMed  Google Scholar 

  • Defronzo, R. A., Simonson, D., Ferrannini, E. & Barret, E. 1981. Insulin resistance: a universal finding in diabetic states. Bull Schweiz Akad Med Wiss, 1981–1982:223–238.

  • Dostal V, Link CD (2010) Assaying beta amyloid toxicity using a transgenic C. elegans model. J Visualized Exper 44. doi:10.3791/2252.

  • Egefjord L, Geji M, Moller A, Brandgaard H, Al. E (2012) Effects of liraglutide on neurodegeneration, blood flow and cognition in Alzheimer’s disease - protocol for a controlled, randomized double-blind trial. Danish Med J 59:1–4

    Google Scholar 

  • Elahi M, Hasan Z, Motoi Y, Matsumoto SE, Ishiguro K, Hattori N (2016) Region-specific vulnerability to oxidative stress, neuroinflammation, and tau hyperphosphorylation in experimental diabetes mellitus mice. J Alzheimers Dis 25:25

    Google Scholar 

  • Eldar-Finkelman H, Schreyer SA, Shinohara MM, Leboeuf RC, Krebs EG (1999) Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6 J mice. Diabetes 48:1–5

    Article  Google Scholar 

  • Fita IG, Enciu A, Stanoiu BP (2011) New insights on Alzheimer’s disease diagnostic. Romanian J Morphol Embryol 52:975–979

    Google Scholar 

  • Hiltunen M, Khandelwal VK, Yaluri N, Tiilikainen T, Tusa M, Koivisto H, Krzisch M, Vepsalainen S, Makinen P, Kemppainen S, Miettinen P, Haapasalo A, Soininen H, Laakso M, Tanila H (2012) Contribution of genetic and dietary insulin resistance to Alzheimer phenotype in APP/PS1 transgenic mice. J Cell Mol Med 16:1206–1222

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ho L, Qin W, Pompl PN, Xiang Z, Wang J, Zhao Z, Peng Y, Cambareri G, Rocher A, Mobbs CV, Hof PR, Pasinetti GM (2004) Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer’s disease. FASEB J 18:902–904

    CAS  PubMed  Google Scholar 

  • Hofman A, Ott A, Breteler MM (1997) Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam Study. Lancet 349:151–154

    Article  CAS  PubMed  Google Scholar 

  • Hoyer S (1997) Models of Alzheimer’s disease: cellular and molecular aspects. N Neural Transm 49:11–21

    CAS  Google Scholar 

  • Hyun J, Hashimoto C (2011) Physiological effects of manipulating the level of insulin-degrading enzyme in insulin-producing cells of drosophila. Fly 5:53–57

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • International Diabetes Federation 2013. IDF diabetes atlas. 6th ed

  • Ke YD, Delerue F, Gladbach A, Gotz J, Ittner LM (2009) Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer’s disease. PLoS One 4:0007917

    Article  Google Scholar 

  • Kim KW, Donato JJ, Berglund ED (2012) FOXO1 in the ventromedial hypothalamus regulates energy balance. J Clin Invest 122:2578–2589

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Knight EM, Martins IVA, Gomosgoz S, Allan SM, Lawrence CB (2014) High-fat diet-induced memory impairment in triple-teansgenic Alzheimer’s disease (3xTgAD) mice is independent of chnages in amyloid and tau pathology. Neurobiol Aging 35:1821–1832

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kohjima M, Sun Y, Chan L (2010) Increased food intake leads to obesity and insulin resistance in the tg2576 Alzheimer’s disease mouse model. Endocrinology 151:1532–1540

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kumar J, Park KC, Awasthi A, Prasad B (2015) Silymarin extends lifespan and reduces proteotoxicity in C. elegans Alzheimer’s model. CNS Neurol Disord Drug Targets 14:295–302

    Article  CAS  PubMed  Google Scholar 

  • Leboucher, A., Laurent, C., Fernandez-Gomez, F. J., Burnouf, S., Troquier, L., Eddarkaoui, S., Demeyer, D., Caillierez, R., Zommer, N., Vallez, E., Bantubungi, K., Breton, C., Pigny, P., Buee-Scherrer, V., Staels, B., Hamdane, M., Tailleux, A., Buee, L. & Blum, D. 2013. Detrimental effects of diet-induced obesity on tau pathology are independent of insulin resistance in tau transgenic mice. Diabetes, 62, 1681–1688.

  • Lenzen S (2008) The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51:216–226

    Article  CAS  PubMed  Google Scholar 

  • Li Z, Zhang W, Sima AF (2007) Alzheimer-like changes in rat models of spontaneous diabetes. Diabetes 56:1817–1824

    Article  CAS  PubMed  Google Scholar 

  • Llorens-Martin, M., Jurado, J., Hernandez, F. & Avila, J. 2014. GSK-3beta, A pivotal kinase in Alzheimer disease. Front Mol Neurosci, 7:46

  • Madhavadas S, Kutty BM, Subramanian S (2014) Amyloid beta lowering and cognition enhancing effects of ghrelin receptor analog [D-Lys (3)] GHRP-6 in rat model of obesity. Indian J Biochem Biophys 51:257–262

    CAS  PubMed  Google Scholar 

  • Mehla J, Chauhan BC, Chauhan NB (2014) Experimental induction of type 2 diabetes mellitusin aging-accelerated mice triggered Alzheimer-like pathology and memory deficits. J Alzheimers Dis 39:145–162

    CAS  PubMed  PubMed Central  Google Scholar 

  • Meusel, L., Tchistiakova, E., Yuen, W., Machintosh, B. J., Anderson, N. D., & Greenwood, C. R. 2012. Cognitive decline and dmentia risk in type 2 diabetes. J Curr Clin Care 2(1): 6–16.

  • Morcos M, Hutter H (2009) The model Caenorhabditis elegans in diabetes mellitus and Alzheimer’s disease. J Alzheimers Dis 16:897–908

    PubMed  Google Scholar 

  • Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003) TRiple-transgenic model of Alzheimer’s disease with plaques and tangle, intracellular Abeta and synaptic dysfunction. Neuron 39:409–421

    Article  CAS  PubMed  Google Scholar 

  • Ogden CL, Carroll MD, Kit BK, Flegal KM (2012) Prevaleve of obesity in the United States, 2009–2010. NCHS Data Brief 82:1–8

  • Onken B, Driscoll M (2010) Metformin induced a dietary restriction-like state and the oxidative stress response to extend C. elegans healthspan via AMPK, LKB1 and SKN-1. PLoS One 5(1):e8758

    Article  PubMed  PubMed Central  Google Scholar 

  • Parikh NM, Morgan R, Kunik ME (2012) Risk facotrs for dementia in pateints over 65 with diabetes. Int J Geriatr Psychiatry 26:749–757

    Article  Google Scholar 

  • Phiel CJ, Wilson CA, Lee VM, Klein PS (2003) GSK-alpha regulates production of Alzheimer’s disease amyloid-beta peptides. Nature 423:435–439

    Article  CAS  PubMed  Google Scholar 

  • Plaschke K, Kopitz J, Siegelin M, Schliebs R, Salkovic-Petrisic M, Riederer P, Hoyer S (2010) Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice. J Alzheimers Dis 19:691–704

    CAS  PubMed  Google Scholar 

  • Qu, Z., Li, L., Sun, X., Zhao, Y., Zhang, J., Geng, Z., Fu, J. & Ren, Q. 2014. Glycogen synthase kinase 3 regulates production of amyloid beta peptide and tau phosphorylation in diabetic rat brain. Sci World J, 2014:878123.

  • Ramasamy R, Vannucci SJ, Yan SS, Herold K, Yan SF, Schmidt AM (2005) Advanced glycation end products and RAGE: a common thread in aging, diabetes neurodegeneration and inflammation. Glycobiology 15(7):16R–28R

    Article  CAS  PubMed  Google Scholar 

  • Ren H, Plum-Morschel L, Gutierrez-Juarez R, AL. E (2013) Blunted refeeding response and increased locomotor activity in mice lacking FoxO1 in synapsin-Cre-expressing neurons. Diabetes 62:3373–3383

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Saharia, K., Arya, U., Kumar, R., Sahu, R., Das, C. K., Gupta, K., Dwivedi, H. & Subramaniam, J. R. 2012. Reserpine modulates neurotransmitter release to extend lifespan and alleviate age-dependent Abeta proteotoxicity in Caenorhabditis elegans. Exp Gerontol, 47, 188–197.

  • Schubert M, Brazil D, Burks DJ (2003) Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation. J Neurosci 23:7084–7092

    CAS  PubMed  Google Scholar 

  • Schubert M, Gautam D, Surjo D, et al. (2004) Role for neuronal insulin resistance in neurodegenerative diseases. Proc Natl Acad Sci U S A 101:3100–3105

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sharma DR, Wani WY, Sunkaria A, Kandimalla RJ, Sharma RK, Verma D, Bal A, Gill KD (2016) Quercetin attenuates neuronal death against aluminum-induced neurodegeneration in the rat hippocampus. Neuroscience 324:163–176

    Article  CAS  PubMed  Google Scholar 

  • Sohal, R. S., Weindruch, R. 1996. Oxidative stress, caloric restriction and aging. Science, 273(5271), 59–63.

  • Son JH, Shim JH, Kim KH, Ha JY, Han JY (2012) Neuronal autophagy and neurodegenerative diseases. Exp Mol Med 44:89–98

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Stoica L, Zhu PJ, Huang W, Zhou H, Kozma SC, Costa-Mattioli M (2011) Selective pharmacogenetic inhibition of mammalian target of rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage. Proc Natl Acad Sci U S A 108:3791–3796

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tilson HA, Peterson NJ (1987) Colchicine as an investigative tool in neurobiology. Toxicology 46:159–173

    Article  CAS  PubMed  Google Scholar 

  • Tsuda M, Kobayashi T, Matsuo T, Aigaki T (2010) Insulin-degrading enzyme antagonizes insulin-dependent tissue growth and Abeta-induced neurotoxicity in drosophila. FEBS Lett 584:2916–2920

    Article  CAS  PubMed  Google Scholar 

  • Umegaki H (2012) Neurodegeneration in diabetes mellitus. Adv Exp Med Biol 724:258–265

    Article  CAS  PubMed  Google Scholar 

  • Van Dijk G, Van Heijningen S, Reijne AC, Nyakas C, Van Der Zee EA, Eisel ULM (2015) Integrative neurobiology of metabolic diseases, nueorinflammation, and neurodegeneration. Front Neurosci 9:1–19

    Article  Google Scholar 

  • Vandal M, White PJ, Tremblay C, St-Amour I, Chevrier G, Emond V, Lefrancois D, Virgili J, Planel E, Giguere Y, Marette A, Calon F (2014) Insulin reverses the high-fat diet-induced increase in brain Abeta and improves memory in an animal model of Alzheimer disease. Diabetes 63(12):4291–4301

    Article  CAS  PubMed  Google Scholar 

  • Yaffe K, Lindquist K, Schwartz AV, Vitartas C, Vittinghoff E, Satterfied S, Simonsick EM, Launer L, Rosano C, Cauley JA, Harris T (2011) Advanced glycation end product level, diabetes, and accelerated cognitive aging. Neurology 77(14):1351–1356

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Molecular Endocrinology, Department of Anatomy, Faculty of Basic Medical Sciences, College of Health Sciences, University of Ilorin, P.M.B. 1515, Ilorin, Nigeria

    O. B. Akinola

Authors
  1. O. B. Akinola
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to O. B. Akinola.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Akinola, O.B. Sweet old memories: a review of the experimental models of the association between diabetes, senility and dementia. Metab Brain Dis 31, 1003–1010 (2016). https://doi.org/10.1007/s11011-016-9876-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-016-9876-0

Keywords

Search

Navigation